Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial
Xu, Mingtong, Sun, Kan, Xu, Wenjie, Wang, Chuan, Yan, Dewen, Li, Shu, Cong, Li, Pi, Yinzhen, Song, Weihong, Sun, Qingyuan, Xiao, Rijun, Peng, Weixia, Wang, Jianping, Peng, Hui, Zhang, Yawei, Duan, Peng, Zhang, Meiying, Liu, Jianying, Huang, Qingmei, Li, Xuefeng, Bao, Yan, Zeng, Tianshu, Wang, Kun, Qin, Li, Wu, Chaoming, Deng, Chunying, Huang, Chenghu, Yan, Shuang, Zhang, Wei, Li, Meizi, Sun, Li, Wang, Yanjun, Li, HongMei, Wang, Guang, Pang, Shuguang, Zheng, Xianling, Wang, Haifang, Wang, Fujun, Su, Xiuhai, Ma, Yujin, Li, Ziling, Xie, Zuoling, Xu, Ning, Ni, Lin, Zhang, Li, Deng, Xiangqun, Pan, Tianrong, Dong, Qijuan, Wu, Xiaohong, Shen, Xingping, Zhang, Xin, Zou, Qijing, Jiang, Chengxia, Xi, Jue, Ma, Jianhua, Sun, Jingchao, Yan, Li
Published in BMC medicine (09.10.2023)
Published in BMC medicine (09.10.2023)
Get full text
Journal Article